On Mar 30, 7:52 am, Steven Swan <
jingles...@gmail.com> wrote:
> My name is Steven A. Swan. I am just writing to let you know that
> after suffering from psoriasis for almost 40 years, I finally
> discovered the true cause of it, as well as the quick, easy, safe, and
> inexpensive cure for it. I would like to share them with you.
>
> Psoriasis is caused by a microscopic parasite which is very common in
> our pets. It is also very common in or on much of our food. I used the
> cure I discovered to cure my own psoriasis.
>
> To try to disseminate this information to as many psoriasis sufferers
> as possible, I have established a website with the comprehensive, step-
> by-step procedure for curing psoriasis for no money up-front. The only
> thing I ask is that anyone successfully curing their psoriasis using
> my information make a donation so that I can try to reach and help as
> many other psoriasis sufferers as possible.
>
> The website is entitled The Suppressed Cure for Many Diseases and it
> is located
atwww.diseasecurer.com. (After studying alternative health
> information for many years, I have discovered the causes of and the
> cures for a number of other diseases, as well.) Anyone wishing the
> cure for psoriasis can send an email requesting it to
>
or...@diseasecurer.com and I will email it to her or him in PDF
> format.
>
> Please share this information with as many others as you can. As soon
> as enough people become aware of this, we will be able to eradicate
> psoriasis.
>
> Please check this information out. It is not a scam. However I am
> finding it somewhat difficult disseminating this information because
> the mainstream medical establishment, including the big pharmaceutical
> companies, have such a stranglehold on health care information.
>
> All the best to you.
>
> Sincerely yours,
>
> Steven A. Swan
> The Suppressed Cures for Many Diseases
Steven,
Did you check this group for your cure?
And the exACT cause of psoriasis? <G>
And...
I see you also had asthma for 57 years?
I googled your profile for all ten hits so FAR:
http://groups.google.com/group/children-and-asthma/browse_frm/thread/f675411f92c7146d/8869fea2fbca7732#8869fea2fbca7732
[...] The title of the website is The Suppressed Cure for Asthma. It
is
located at
http://www.asthmacurer.com.
I hope that everyone suffering from asthma uses my information to
cure
it. It is a great relief to be able to breathe easy after all of this
time.
<snip>
Congrats on your FOUND health!
Breathe easy... or easier... certainly GLAD i've never had that one on
top
of this flake thingy...<g>
Did you use glutathione at all?
I didn't go to your site, YET.
Or do the download (request) thingy.
As my interest would be technical at this point.
Yet... glutathione being..
NAC (N-acetyl cysteine ) supplement:
1612 hits: NAC + glutathione - pubmed:
http://www.ncbi.nlm.nih.gov/pubmed?term=nac%20glutathione
560 hits: asthma glutathione -pubmed
http://www.ncbi.nlm.nih.gov/pubmed?term=asthma%20glutathione
And since asthma is a Th2 condition and psoriasis a Th1 skew-age.
Glutathione is ONE of the supplements to actually help both conditions
(Th1 + Th2).
(will be doing another autism and glutathione thread soon:)
3577 hits : asthma + Th2 - pubmed
http://www.ncbi.nlm.nih.gov/pubmed?term=asthma%20Th2
But maybe your skin condition is closer to sebopsoriasis as it
does have components of both Th1 and Th2?
Evetsm being the de facto goto in this group ( p ng ):
2570 hits: evetsm - p ng
http://groups.google.com/group/alt.support.skin-diseases.psoriasis/search?q=evetsm&start=0&
seborrheic (ATopic dermatitis -->Th2 skew) forms of psoriasis being
evetsm's forte
btw are you downunder (Oz), in the virgin islands?
http://www.whoismind.com/whois/diseasecurer.com.html
A warmer clime (equatorial regions) for a northern latitude DNA (i'm
guessing your genetics [swan] here;)
would or may lend to both conditions Th1/Th2?
Or a d receptor goof up?
OTOH certainly a D receptor gene could have effects?
In which case:
http://eon.businesswire.com/news/eon/20120329005494/en
Bryan, Garnier & Co initiates coverage of Hybrigenics with a target
price of €2.6
March 29, 2012 05:24 AM Eastern Daylight Time
PARIS--(EON: Enhanced Online News)--Hybrigenics SA (ALHYG), a bio-
pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris,
with a focus on research and development of new treatments against ___
proliferative ___ diseases, today announces the initiation of coverage
of its stock by the investment bank Bryan, Garnier & Co with a target
price of €2.6.
The full Bryan, Garnier & Co report can be found under Corporate /
Investor Relations / Press Releases on the Hybrigenics website.
About Hybrigenics -
www.hybrigenics.com
Hybrigenics is a bio-pharmaceutical company listed (ALHYG) on
Alternext (NYSE-Euronext) in Paris, focusing its internal R&D programs
on innovative targets and therapies for the treatment of proliferative
cancerous or non-cancerous diseases.
Hybrigenics’ current development program is based on ___ inecalcitol,
a vitamin D receptor agonist ___ active by oral administration. Oral
inecalcitol is currently being studied in a clinical trial for the
treatment of moderate-to-severe psoriasis. Oral inecalcitol is also
planned to be tested in chronic lymphocytic leukemia patients. Oral
inecalcitol has already shown excellent tolerance and strong
presumption of efficacy for the first-line treatment of metastastic
castrate-resistant prostate cancer in combination with Taxotere®,
which is the current gold-standard chemotherapeutic treatment for this
indication.
Hybrigenics has a research collaboration with Servier on
deubiquitinating enzymes and their inhibitors in oncology, neurology,
psychiatry, rheumatology, ophthalmology, diabetes and cardiovascular
diseases. Hybrigenics continues to build on its pioneer research
position in the field of ubiquitin-specific proteases by exploring
their role in other areas of particular relevance, such as
inflammation and virology.
Hybrigenics Services SAS, a fully-owned subsidiary, is the market
leader in Yeast Two-Hybrid (Y2H) and related services to identify,
validate and inhibit protein interactions for researchers in all areas
of life sciences, using its ISO 9001-certified high-throughput Y2H
screening platform, its sophisticated bioinformatics tools and
extensive database, along with its chemical library and chemical
screening platform.
***
HYBRIGENICS is listed on the Alternext by NYSE Euronext Paris
ISIN: FR0004153930
Ticker: ALHYG
Contacts
Hybrigenics
Rémi Delansorne,
+33 (0)1 58 10 38 00
CEO
or
NewCap.
Financial communication
Axelle Vuillermet / Pierre Laurent,
+33 (0)1 44 71 94 94
hybri...@newcap.fr
<snip>
This is a good one... i'll add it to my NEXT psor mAb thread?
Ok...
Well... a D3 receptor agonist is key during those northern latitudinal
coldish months.
Eat a FISH...
Or wish it a WHEY... LoL
#2 of 1612
STAT to the ER (fame)
Bohgosity BumaskiL may enjoy this one?
I see cranberry and renal effects coming uP soon? <w>
http://www.ncbi.nlm.nih.gov/pubmed/22445861
Toxicol In Vitro. 2012 Mar 16.
Endoplasmic reticulum stress mediates aristolochic acid I-induced
apoptosis in human renal proximal tubular epithelial cells.
Zhu S, Wang Y, Jin J, Guan C, Li M, Xi C, Ouyang Z, Chen M, Qiu Y,
Huang M, Huang Z.
Source
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou
510006, PR China.
Abstract
Aristolochic acid (AA), derived from the Aristolochia species, has
been associated with aristolochic acid nephropathy (AAN), which has
emerged as a worldwide disease. Aristolochic acid I (AAI) is the main
ingredient of AA, and the underlying mechanisms for AAI-induced
nephrotoxicity are still unclear. In this study, we investigated
whether endoplasmic reticulum (ER) stress was involved in AAI-induced
nephrotoxicity. The results showed that treatment of HK-2 cells (a
human proximal tubular epithelial cell line) with AAI caused an
increase in eukaryotic initiation factor-2α (eIF2α) phosphorylation, X-
box binding protein 1 (XBP1) mRNA splicing and the expression of
glucose-regulated protein (GRP) 78 and CAAT/enhancer-binding protein-
homologous protein (CHOP). These events represent typical markers of
the ER stress-related signaling pathway. Pretreatment with 4-
phenylbutyrate (4-PBA) or salubrinal (Sal) significantly inhibited AAI-
induced apoptosis, indicating the role of ER stress in AAI-induced
apoptosis. In addition, AAI-induced cell death followed an increase of
reactive oxygen species (ROS) formation in HK-2 cells. Pretreatment
with N-acetyl cysteine (NAC) or glutathione (GSH) significantly
inhibited AAI-induced ER stress proteins and cell death, suggesting
that ROS mediate AAI-induced ER stress. Taken together, these results
suggest that the ER stress response is involved in apoptosis induced
by AAI in HK-2 cells, thus offering a new insight into the
nephrotoxicity of AAI.
PMID: 22445861
TCM and fire in the kidneys time?
yep..
Only two hits for Aristolochic acid?
yep.
Aristolochic acid - 2 hits - p ng
http://groups.google.com/group/alt.support.skin-diseases.psoriasis/search?q=Aristolochic+acid+&start=0&
But a caveat is a GOOD thing to keep in mind while testing a myriad of
things on Planet earP... or burP
randall.. to much FUN... is like eating a hotdog sans BUN... (<w><G>)
pass the juncea!
notes:
ps 1
586 hits : brassica juncea -pubmed
http://www.ncbi.nlm.nih.gov/pubmed?term=juncea%20brassica
ps 2
13 hits: brassica juncea - p ng
http://groups.google.com/group/alt.support.skin-diseases.psoriasis/search?q=brassica+juncea&start=0&
#1 of 13 (for BB--Bohgosity BumaskiL -- no less last February 24th)
http://groups.google.com/group/alt.support.skin-diseases.psoriasis/browse_frm/thread/d61e78768af79e42/1d7fb2763462ce1c?lnk=gst&q=brassica+juncea#1d7fb2763462ce1c